For overall survival (OS), higher TFAP2C expression was associated with a shorter OS of BCa patients in the TCGA-BLCA dataset (Figure 1C) and GSE databases (Figure 1D). The gene discussed is TFAP2C; the disease is bladder transitional cell carcinoma.